Key result
Mac-1 deficiency dramatically reduces TAC-induced cardiac dysfunction and remodeling in mice versus wild-type.
Why the study?
The involvement of macrophage-1 antigen (Mac-1) in cardiac remodeling and heart failure caused by pressure overload had not been determined.
Does Mac-1 deficiency ameliorate pressure overloaded heart failure in mice?
Does Mac-1 deficiency ameliorate pressure overloaded heart failure in mice?
Mac-1 deficiency ameliorates pressure overload-induced heart failure and cardiac remodeling in mice by inhibiting macrophage infiltration and M1 polarization.
Answers are grounded in this paper and cite their sources.
Mac-1 inhibition merits study as a pressure-overload HF target; leaves open translation beyond murine models.
Persistent pressure overload commonly leads to pathological cardiac hypertrophy and remodeling, ultimately leading to heart failure (HF). Cardiac remodeling is associated with the involvement of immune cells and the inflammatory response in pathogenesis. The macrophage-1 antigen (Mac-1) is specifically expressed on leukocytes and regulates their migration and polarization. Nonetheless, the involvement of Mac-1 in cardiac remodeling and HF caused by pressure overload has not been determined. The Mac-1-knockout (KO) and wild-type (WT) mice were subjected to transverse aortic constriction (TAC) for 6 weeks. Echocardiography and pressure-volume loop assessments were used to evaluate cardiac function, and cardiac remodeling and macrophage infiltration and polarization were estimated by histopathology and molecular techniques. The findings of our study demonstrated that Mac-1 expression was markedly increased in hearts subjected to TAC treatment. Moreover, compared with WT mice, Mac-1-KO mice exhibited dramatically ameliorated TAC-induced cardiac dysfunction, hypertrophy, fibrosis, oxidative stress and apoptosis. The potential positive impacts may be linked to the inhibition of macrophage infiltration and M1 polarization via reductions in NF-kB and STAT1 expression and upregulation of STAT6. In conclusion, this research reveals a new function of Mac-1 deficiency in reducing pathological cardiac remodeling and HF caused by pressure overload. Additionally, inhibiting Mac-1 could be a potential treatment option for patients with HF in a clinical setting.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2024) studied Heart failure and cardiac remodeling caused by pressure overload. Mac-1 deficiency (Mac-1-knockout) vs. Wild-type (WT) mice was evaluated on Cardiac dysfunction, hypertrophy, fibrosis, oxidative stress and apoptosis. Mac-1 deficiency in mice dramatically ameliorated transverse aortic constriction-induced cardiac dysfunction, hypertrophy, fibrosis, oxidative stress, and apoptosis compared with wild-type mice.
Synapse has enriched 10 related papers. Consider them for comparative context: